Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Macrolide antibiotics and the risk of cardiac arrhythmias.

Albert RK, Schuller JL; COPD Clinical Research Network.

Am J Respir Crit Care Med. 2014 May 15;189(10):1173-80. doi: 10.1164/rccm.201402-0385CI. Review.

2.

Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.

Chang AB, Grimwood K, Robertson CF, Wilson AC, van Asperen PP, O'Grady KA, Sloots TP, Torzillo PJ, Bailey EJ, McCallum GB, Masters IB, Byrnes CA, Chatfield MD, Buntain HM, Mackay IM, Morris PS.

Trials. 2012 Aug 31;13:156. doi: 10.1186/1745-6215-13-156.

3.

Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial.

Valery PC, Morris PS, Grimwood K, Torzillo PJ, Byrnes CA, Masters IB, Bauert PA, McCallum GB, Mobberly C, Chang AB.

BMC Pediatr. 2012 Aug 14;12:122.

4.

Role of macrolide therapy in chronic obstructive pulmonary disease.

Martinez FJ, Curtis JL, Albert R.

Int J Chron Obstruct Pulmon Dis. 2008;3(3):331-50. Review.

5.

Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells.

Imamura Y, Yanagihara K, Mizuta Y, Seki M, Ohno H, Higashiyama Y, Miyazaki Y, Tsukamoto K, Hirakata Y, Tomono K, Kadota J, Kohno S.

Antimicrob Agents Chemother. 2004 Sep;48(9):3457-61.

6.

Low-dose, long-term macrolide therapy in asthma: An overview.

Hatipoglu U, Rubinstein I.

Clin Mol Allergy. 2004 Mar 16;2(1):4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk